商品描述
The book covers the latest scientific advances in biomarker identification, sensor design, and point-of-care diagnostic systems tailored for early-stage prostate cancer. It explains how biosensors function, their role in overcoming limitations of traditional diagnostic tools, and their impact on personalized medicine. The book focuses on integrating interdisciplinary knowledge, combining insights from biotechnology, nanotechnology, and clinical oncology. It includes chapters that explain different types of biosensors, electrochemical, optical, and nanomaterial-based, while discussing their real-world applications and clinical relevance. A special chapter is dedicated to prostate cancer-specific biomarkers and sensor platforms, providing readers with a focused understanding of disease-targeted diagnostics.
This book benefits researchers, clinicians, biomedical engineers, and graduate students by offering practical insights and future directions in diagnostic innovation. It serves as a valuable resource for anyone aiming to improve early detection and management of prostate cancer, making it essential for academic, research, and clinical settings.
商品描述(中文翻譯)
本書涵蓋了在生物標記物識別、感測器設計以及針對早期前列腺癌的即時診斷系統方面的最新科學進展。它解釋了生物感測器的運作原理、它們在克服傳統診斷工具限制方面的角色，以及它們對個人化醫療的影響。本書專注於整合跨學科知識，結合生物技術、奈米技術和臨床腫瘤學的見解。書中包括解釋不同類型的生物感測器的章節，包括電化學、光學和基於奈米材料的感測器，同時討論它們在現實世界中的應用和臨床相關性。
特別有一章專門介紹針對前列腺癌的特定生物標記物和感測平台，為讀者提供針對疾病的診斷的深入理解。
本書對研究人員、臨床醫生、生物醫學工程師和研究生都有益處，提供了實用的見解和診斷創新的未來方向。它是任何希望改善前列腺癌早期檢測和管理的人士的重要資源，對於學術、研究和臨床環境而言都是必不可少的。
作者簡介
Shriyansh Srivastava holds a B. Pharmacy degree from Dr. A.P.J. Abdul Kalam Technical University, Lucknow, Uttar Pradesh, India, and an M. Pharmacy (Pharmacology) degree from ISF College of Pharmacy, Moga, Punjab, India. PhD in Pharmacology & Clinical Research at Delhi Pharmaceutical Sciences and Research University, New Delhi, India. He is currently serving as a guest editor for BMC Microbiology, a Springer Nature (Q1) Journal, with an IF of 4.2. He actively engages in cutting-edge research and has published over 75+ research and review articles in prestigious international journals. His work in the Lancet series, including Lancet Microbe, with an impact factor of 38.2, highlights his scholarly excellence and contributes to a cumulative impact factor of over 250+. Shriyansh has secured three patents and authored 15 book chapters in his field. Currently, he is editing 11 academic books with major publishers, including Elsevier, Wiley, Springer, and Taylor & Francis. He is a potential reviewer in Elsevier, Springer, Taylor & Francis, and Wiley Journals. His strong educational and research background make him a leading voice in pharmacology and virology. Dr. Molakpogu Ravindra Babu is currently serving as a Professor and Program Chair in Department of Pharmacy, School of Medical & Allied Sciences, Galgotias University. Previously he served as a professor in Lovely Professional University, Punjab, India. Dr. Babu has a vast experience of more than 15 years in teaching and research. His key research area includes development of minimal invasive drug delivery systems and nano delivery systems. He has guided 12 M. Pharm projects and 35 B. Pharm Projects. He is currently working on microneedle technology and various lipid based nanoparticulate delivery systems. He published 2 books in Springer Nature and 15 book chapters in various publishers including Elsevier, Springer, Taylor, and Francis. Currently, he is editing two books with Springer Nature and 3 books with Wiley publishers. Dr. Babu is serving as a reviewer for number of reputed journals of Springer Nature, Elsevier, and Bentham Publishers. He is having a cumulative impact factor of more than 300 and H-index of 12. Dr. Shashank Shekhar is an Associate Professor in the Department of Radiotherapy at AIIMS Gorakhpur. He holds an MD in Radiotherapy from Maulana Azad Medical College, Delhi University. With a strong background in clinical oncology and pharmacovigilance, Dr. Shekhar has contributed to multiple peer-reviewed publications and participates actively in ethical oversight as a member of the Institutional Human Ethics Committee. His academic and clinical interests focus on advancing patient safety and cancer treatment practices in India.
作者簡介(中文翻譯)
Shriyansh Srivastava 擁有印度烏塔爾邦勒克瑙的 Dr. A.P.J. Abdul Kalam 技術大學的藥學學士學位，以及印度旁遮普的 ISF 藥學院的藥學碩士學位（藥理學）。他在印度新德里的德里藥學科學與研究大學獲得藥理學與臨床研究的博士學位。目前，他擔任 BMC Microbiology 的客座編輯，這是 Springer Nature（Q1）期刊，影響因子為 4.2。他積極參與前沿研究，並在多個知名國際期刊上發表了超過 75 篇研究和綜述文章。他在《柳葉刀》系列中的工作，包括《柳葉刀微生物》，影響因子為 38.2，突顯了他的學術卓越，並為累計影響因子超過 250 做出了貢獻。Shriyansh 已獲得三項專利，並在其領域撰寫了 15 篇書章。目前，他正在與主要出版商編輯 11 本學術書籍，包括 Elsevier、Wiley、Springer 和 Taylor & Francis。他是 Elsevier、Springer、Taylor & Francis 和 Wiley 期刊的潛在審稿人。他強大的教育和研究背景使他成為藥理學和病毒學的領軍人物。 Dr. Molakpogu Ravindra Babu 目前擔任 Galgotias 大學醫學與相關科學學院藥學系的教授及課程主任。此前，他曾在印度旁遮普的 Lovely Professional University 擔任教授。Dr. Babu 在教學和研究方面擁有超過 15 年的豐富經驗。他的主要研究領域包括開發微創藥物傳遞系統和納米傳遞系統。他指導了 12 個碩士藥學項目和 35 個學士藥學項目。目前，他正在研究微針技術和各種基於脂質的納米顆粒傳遞系統。他在 Springer Nature 出版了 2 本書，並在包括 Elsevier、Springer、Taylor 和 Francis 在內的多家出版商發表了 15 篇書章。目前，他正在與 Springer Nature 編輯兩本書，並與 Wiley 出版商編輯三本書。Dr. Babu 是多本 Springer Nature、Elsevier 和 Bentham Publishers 的知名期刊的審稿人。他的累計影響因子超過 300，H 指數為 12。 Dr. Shashank Shekhar 是 AIIMS Gorakhpur 放射治療系的副教授。他擁有德里大學 Maulana Azad 醫學院的放射治療醫學博士學位。Dr. Shekhar 在臨床腫瘤學和藥物監測方面具有堅實的背景，並為多篇同行評審的出版物做出了貢獻，並作為機構人類倫理委員會的成員積極參與倫理監督。他的學術和臨床興趣集中在推進印度的病人安全和癌症治療實踐上。
